News and Announcements
Proteomics International Receives R&D Tax Incentive
- Published November 18, 2015 12:06PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
18th November 2015, ASX Announcement
Life sciences company Proteomics International Laboratories Ltd (ASX: PIQ) (the Company, PILL) is pleased to announce it has received an Australian Government R&D Tax Incentive payment of $309,010 for the year ending 30 June 2015.
The Company received the R&D Tax Incentive after spending in excess of $700,000 on R&D activities within its world leading proteomics-focused business in the 2014-15 financial year.
The funds from the R&D Tax Incentive will complement PILL’s existing cash reserves and be used to continue to advance the application and commercialisation of the Company’s products and services derived from its proteomics-based technology platform.
Proteomics is the industrial scale study of the structure and function of proteins and PILL is recognised as a global leader in its field.
To read the full announcement, please click here.
Company Updates
The Yield Illusion: Inside RAM’s Strategy to Withstand the Credit Shakeout
As interest rates reprice in 2026, the rush into private credit has created a dangerous trap for yield-hungry investors. Real Asset Management Group CEO Scott Kelly exposes the “yield illusion” dominating the market and explains why an origination-led, low-arrears mortgage strategy is the ultimate defense against an impending credit shakeout.
Office sector ‘unloved’ no more: Acure’s $80m Brisbane bet
While institutional investors remain wary of the office sector, Acure Asset Management is doubling down. Founder Angelo Del Borrello explains the “unloved” asset strategy behind his latest $80 million Brisbane acquisition and why the 2032 Olympics are creating a unique arbitrage opportunity for private syndicates.
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
Backed By Leading Investment Groups and Family Offices
